Notably, inhibiting the ferroptosis regulators CHAC1 and ACSL4 in A375 cells reversed these effects, highlighting ferroptosis as a critical mediator of T-cell activation, potentially through the release of immunogenic signals from dying tumor cells. This evidence concerns the gene ACSL4 and neoplasm.